JK Organization   Report issue

For profit Phase 2 Phase 3
Founded: New Delhi India (1888)
Status: No NME R&D (1888)

Organization Overview

First Clinical Trial
2009
NCT01019824
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CliniRx | CliniRx Tangent Research

Active Ingredients

Drugs in Phase 3 Trials (2)

estradiol (progynon depot) (2 trials)

ralfinamide (1 trial)

Drugs in Phase 2 Trials (1)

jnj-39393406 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 2)

Disease (Phase 3)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3